Home Cart 0 Sign in  
X

[ CAS No. 41330-49-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 41330-49-8
Chemical Structure| 41330-49-8
Chemical Structure| 41330-49-8
Structure of 41330-49-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 41330-49-8 ]

Related Doc. of [ 41330-49-8 ]

Alternatived Products of [ 41330-49-8 ]

Product Details of [ 41330-49-8 ]

CAS No. :41330-49-8 MDL No. :MFCD07781654
Formula : C7H6ClN3 Boiling Point : -
Linear Structure Formula :- InChI Key :CXLAMAWMZAQBKK-UHFFFAOYSA-N
M.W : 167.60 Pubchem ID :11309738
Synonyms :

Calculated chemistry of [ 41330-49-8 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 2.0
Molar Refractivity : 45.51
TPSA : 54.7 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.02 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.9
Log Po/w (XLOGP3) : 1.83
Log Po/w (WLOGP) : 1.81
Log Po/w (MLOGP) : 1.38
Log Po/w (SILICOS-IT) : 1.95
Consensus Log Po/w : 1.57

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.64
Solubility : 0.386 mg/ml ; 0.0023 mol/l
Class : Soluble
Log S (Ali) : -2.6
Solubility : 0.422 mg/ml ; 0.00252 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.16
Solubility : 0.116 mg/ml ; 0.00069 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.57

Safety of [ 41330-49-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 41330-49-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 41330-49-8 ]
  • Downstream synthetic route of [ 41330-49-8 ]

[ 41330-49-8 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 4812-45-7 ]
  • [ 41330-49-8 ]
YieldReaction ConditionsOperation in experiment
544 mg With tin(II) chloride dihdyrate In ethanolReflux 1.00 g (5.06 mmol) of 3-chloro-5-nitro-1H-indazole wassuspended in 50 ml of ethanol, and 5.71 g (25.3 mmol) of tin(II) chloridedihydrate were added. The mixture was left to stir at reflux overnight,saturated aqueous sodium bicarbonate solution was then added and the mixturewas extracted three times with ethyl acetate. The combined organic phases weredried over magnesium sulphate and the solvent was removed under reducedpressure. The mixture was triturated with ten'-butyl methyl ether and the solidwas filtered off with suction. Yield: 544 mg (purity 90percent, 58percent of theory)
Reference: [1] Journal of Chemical Research, Miniprint, 1990, # 11, p. 2601 - 2615
[2] Journal of Medicinal Chemistry, 2003, vol. 46, # 26, p. 5663 - 5673
[3] Patent: US2016/52884, 2016, A1, . Location in patent: Paragraph 0649-0652
[4] Patent: KR2015/137095, 2015, A, . Location in patent: Paragraph 0867-0870
  • 2
  • [ 19335-11-6 ]
  • [ 41330-49-8 ]
Reference: [1] Patent: WO2006/17443, 2006, A2, . Location in patent: Page/Page column 128
  • 3
  • [ 5401-94-5 ]
  • [ 41330-49-8 ]
Reference: [1] Journal of Medicinal Chemistry, 2003, vol. 46, # 26, p. 5663 - 5673
[2] Journal of Chemical Research, Miniprint, 1990, # 11, p. 2601 - 2615
Same Skeleton Products
Historical Records